Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunization therapy in Alzheimer's disease.

Felix Mor1, Alon Monsonego

  • 1Tel-Aviv University, Weizmann Institute of Science Department of Immunology, Rehovot, Israel. felix.mor@weizmann.ac.il

Expert Review of Neurotherapeutics
|June 1, 2006
PubMed
Summary

Immunization targeting amyloid-beta peptide offers a promising new avenue for Alzheimer's disease (AD) treatment. This approach aims to combat cognitive decline in AD patients, unlike current symptomatic therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impaired nucleocytoplasmic transport in SOD1-mediated ALS.

Molecular neurodegeneration·2026
Same author

Weight loss aggravates obesity-induced hypothalamic inflammation in mid-aged mice.

GeroScience·2025
Same author

CD4 T cells acquire Eomesodermin to modulate cellular senescence and aging.

Nature aging·2025
Same author

Exploring the Impact of a High-Fat Diet on Brain Homeostasis: A Comprehensive Analysis of the Absence of Inflammation.

Molecular nutrition & food research·2025
Same author

Structural and functional insights of ZnT1 C-terminal domain as a regulator of zinc transport.

Scientific reports·2025
Same author

Gender Differences in Coping Strategies and Life Satisfaction Following Cognitive-Behavioral and Mindfulness-Based Intervention for Crohn's Disease: A Randomized Controlled Trial.

Journal of clinical medicine·2025

Area of Science:

  • Neurodegenerative diseases
  • Immunology
  • Alzheimer's disease research

Background:

  • Alzheimer's disease (AD) is a prevalent and severe neurodegenerative disorder.
  • The increasing incidence of AD in Western societies presents a significant public health challenge.
  • Current AD treatments are largely symptomatic and fail to halt or reverse cognitive impairment.

Purpose of the Study:

  • To provide an overview of immunization therapy as a novel treatment for Alzheimer's disease.
  • To examine the future potential and prospects of amyloid-beta peptide immunization in AD therapeutics.

Main Methods:

  • Review of experimental Alzheimer's disease models.
  • Analysis of immunization strategies targeting amyloid-beta peptide.
  • Evaluation of therapeutic efficacy and safety data.

Main Results:

  • Immunization against amyloid-beta peptide has emerged as a key experimental therapeutic strategy for AD.
  • This approach shows potential for modifying the disease course, unlike existing treatments.
  • Further research is ongoing to optimize and validate this therapeutic modality.

Conclusions:

  • Alzheimer's disease immunization represents an exciting frontier in AD treatment development.
  • This therapeutic strategy holds promise for addressing the unmet need for disease-modifying therapies.
  • Future prospects for amyloid-beta peptide immunization in clinical settings warrant continued investigation.

Related Experiment Videos